Research & Development



  雲瑯陪著汲黯喝了一杯酒笑道︰“你的這張白鹿幣真的好難看啊。”   孟大,孟二如今徹底的成為了家禽飼養專家,兄弟二人齊齊的獲封農學博士,已經讓他的父母歡喜若狂了。青娱乐官网极品盛宴   誰都知道雲家錢很多。青娱乐最新官网   看了這雙眼楮,屋子里的其余東西就不用看了,這是一雙極為精彩的眼楮,只要看透這雙眼楮,就像是已經知道了天地間最大的秘密。   雲瑯摘了一片麻葉放進嘴里,味道苦澀……或許,只有等到秋日收割掉這些麻,雲氏與長門宮才能繼續回復往日的模樣。青娱乐视频极品视觉宴   曹襄得意的點頭道︰“然也!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo